Kpcb Pandemic & Bio Defense Fund Llc - Net Worth and Insider Trading

Kpcb Pandemic & Bio Defense Fund Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kpcb Pandemic & Bio Defense Fund Llc owns 1 companies in total, including Sagimet Biosciences Inc (SGMT) .

Click here to see the complete history of Kpcb Pandemic & Bio Defense Fund Llc’s form 4 insider trades.

Insider Ownership Summary of Kpcb Pandemic & Bio Defense Fund Llc

Ticker	Comapny	Transaction Date	Type of Owner
SGMT	Sagimet Biosciences Inc	2023-07-13	10 percent owner

Kpcb Pandemic & Bio Defense Fund Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kpcb Pandemic & Bio Defense Fund Llc Ownership Network

Ownership Network List of Kpcb Pandemic & Bio Defense Fund Llc

No Data

Ownership Network Relation of Kpcb Pandemic & Bio Defense Fund Llc

Kpcb Pandemic & Bio Defense Fund Llc Owned Company Details

What does Sagimet Biosciences Inc do?

Who are the key executives at Sagimet Biosciences Inc?

Kpcb Pandemic & Bio Defense Fund Llc is the 10 percent owner of Sagimet Biosciences Inc. Other key executives at Sagimet Biosciences Inc include director & President & CEO David Happel , 10 percent owner New Enterprise Associates 13 Lp , and 10 percent owner Scott D Sandell .

Sagimet Biosciences Inc (SGMT) Insider Trades Summary

Over the past 18 months, Kpcb Pandemic & Bio Defense Fund Llc made no insider transaction in Sagimet Biosciences Inc (SGMT). Other recent insider transactions involving Sagimet Biosciences Inc (SGMT) include a net purchase of 14,290 shares made by David Happel , a net purchase of 29,338 shares made by New Enterprise Associates 13 Lp , and a net purchase of 46,875 shares made by Beth C Seidenberg .

In summary, during the past 3 months, insiders sold 0 shares of Sagimet Biosciences Inc (SGMT) in total and bought 12,100 shares, with a net purchase of 12,100 shares. During the past 18 months, 662 shares of Sagimet Biosciences Inc (SGMT) were sold and 91,165 shares were bought by its insiders, resulting in a net purchase of 90,503 shares.

Sagimet Biosciences Inc (SGMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sagimet Biosciences Inc Insider Transactions

No Available Data

Kpcb Pandemic & Bio Defense Fund Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Kpcb Pandemic & Bio Defense Fund Llc. You might contact Kpcb Pandemic & Bio Defense Fund Llc via mailing address: 2750 Sand Hill Rd, Menlo Park Ca 94025.

Discussions on Kpcb Pandemic & Bio Defense Fund Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.